Basic Stats
| LEI | 213800V3NCQTY7IED471 |
| CIK | 1625297 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Indivior PLC
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission F |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission F |
|
| August 22, 2025 |
Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”), dated as of January 1, 2025 (the “Effective Date”), is made and entered into by Indivior, Inc. (the “Company”) and Ryan Preblick (the “Executive”). In consideration of the mutual promises set forth below and other good and valuable consideration, the receipt and sufficiency of which the parties acknowledge, the Company |
|
| August 22, 2025 |
CONFIDENTIALITY, PROPRIETARY RIGHTS AND NON-COMPETITION AGREEMENT Exhibit 10.2 CONFIDENTIALITY, PROPRIETARY RIGHTS AND NON-COMPETITION AGREEMENT This Confidentiality, Proprietary Rights and Non-Competition Agreement (the “Agreement”) is entered into as of January 1, 2025 (the “Effective Date”), by Indivior, Inc. (the “Employer”, collectively with its affiliates, as in existence from time to time, the “Group”) and Ryan Preblick (the “Employee”). Employer and Empl |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporat |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| July 31, 2025 |
Form of Non-Executive Director Letter of Appointment Exhibit 10.2 [Date] [Name] [Address] [City, ST Zip] Re: APPOINTMENT AS NON-EXECUTIVE DIRECTOR Dear [Name], We are delighted that you are [willing to join us][continuing] as a Non-Executive Director of Indivior PLC (the “Company”), your appointment to be effective from [Date]. I am now writing to formalise and confirm the terms of such appointment. It is agreed that this will be a contract for serv |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37835 Indivior PLC (Exact name of registrant as specified in |
|
| July 31, 2025 |
Form of Non-Executive Director Deed of Indemnity Exhibit 10.3 [Date] (1) Indivior PLC (2) [Name] DEED OF INDEMNITY CONTENTS CLAUSE PAGE 2. INDEMNITY 4 3. EXCLUSIONS AND LIMITATIONS 4 4. FUNDING OF DEFENCE COSTS 5 5. NOTIFICATION AND CONDUCT OF CLAIMS 6 6. NO DOUBLE RECOVERY 7 7. TAX 8 8. D&O INSURANCE 8 9. SUBROGATION 9 10. TERM 9 11. ASSIGNMENT 9 12. ENTIRE AGREEMENT 9 13. SEVERANCE 10 14. NOTICES 10 15. VARIATION 11 16. WAIVER 11 17. COUNTERPA |
|
| July 31, 2025 |
EX-99.2 Q2 2025 Results July 31, 2025 Exhibit 99.2 c Important Cautionary Statement Regarding Forward-looking Statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, express and implied statements regarding: the Company’s financial guidance including revenue, operating, and profit margins for 2025, and its medium- a |
|
| July 31, 2025 |
EX-99.1 Exhibit 99.1 Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance • Q2’25 Total Net Revenue of $302m; Q2’25 SUBLOCADE® Net Revenue of $209m, up 9% Year-over-Year • Indivior Action Agenda Underway to Strengthen Business and Generate Operational Momentum • Conference Call Scheduled for Today at 8:00 A.M. EDT Richmond, VA, July 31, 2025 – Indivior PLC ( |
|
| July 31, 2025 |
09237894 Exhibit 3.1 ARTICLES OF ASSOCIATION of INDIVIOR PLC Public Limited Company (09237894) (Articles adopted by special resolution on 30 October 2014 and amended by special resolution on 23 December 2014, 30 September 2022, 4 May 2023 and 8 May 2025) TABLE OF CONTENTS GLOSSARY 55 3 1.Exclusion of Model Articles The articles prescribed in any legislation relating to companies do not apply as th |
|
| July 31, 2025 |
EX-99.3 Investor Presentation July 31, 2025 For Investor Relations Purposes Only Exhibit 99.3 c Important Cautionary Statement Regarding Forward-looking Statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, express and implied statements regarding: the Company’s financial guidance including revenue, operating, and |
|
| June 30, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 30, 2025 |
Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes Exhibit 99.1 Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes Richmond, VA, June 30, 2025 – Indivior PLC (Nasdaq / LSE: INDV) will be added as a member of the U.S. small-cap Russell 2000® Index, effective after the U.S. market opens today as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest U.S. |
|
| June 24, 2025 |
Indivior Appoints Tony Kingsley to the Board of Directors Exhibit 99.1 Indivior Appoints Tony Kingsley to the Board of Directors Richmond, VA, June 24, 2025 – Indivior PLC (Nasdaq / LSE: INDV) today announced the appointment of Tony Kingsley to the Board of Directors as an Independent Non-Executive Director, effective July 1, 2025. Mr. Kingsley was appointed pursuant to Indivior’s relationship agreement with affiliates of Oaktree Capital Management, L.P. |
|
| June 24, 2025 |
Indivior PLC 234 Bath Road Slough, Berkshire, United Kingdom Exhibit 99.3 Execution Version Indivior PLC 234 Bath Road Slough, Berkshire, United Kingdom June 20, 2025 Keith Humphreys Daniel Ninivaggi Barbara Ryan Mark Stejbach David Wheadon c/o Indivior plc 234 Bath Road Slough, Berkshire, United Kingdom Ladies and Gentlemen: Reference is made to the Purchase Plan dated as of June 18, 2025 (the “Purchase Plan”) by and among (a) Keith Humphreys; (b) Daniel N |
|
| June 24, 2025 |
REDACTED MATERIAL IS MARKED WITH [***]. Purchase Plan Exhibit 99.2 PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED. CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE LIKELY TO CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED WITH [***]. Purchase Plan Purchase Plan, adopted June 18, 2025 (the “Purchase Plan”, and such date, the “Adoption Date”), among: (a) Keit |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission File |
|
| June 2, 2025 |
EX-99.1 Exhibit 99.1 Investor Presentation June 2025 For Investor Relations Purposes Only I N V E S T O R P R E S E N T A T I O N | J U N E 2 0 2 5 Important Cautionary Statement Regarding Forward-looking Statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, express and implied statements regarding expected future |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission File |
|
| June 2, 2025 |
Exhibit 99.1 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE U.K. BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL ACT 2018) Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained Slough, U.K., and Richmond, VA, June 2, |
|
| May 12, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporatio |
|
| May 12, 2025 |
EX-99.1 Exhibit 99.1 The following amendment has been made to the Result of Annual General Meeting (‘AGM’) announcement released on May 8, 2025 at 14:00 under RNS Number 9352H. The number of votes against resolution 6. To elect Dr. David Wheadon, has been updated to 14,624,894. All other details remain unchanged. The full amended text is shown below. Indivior PLC (the ‘Company’) Result of Annual G |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission File |
|
| May 8, 2025 |
Exhibit 99.1 Indivior PLC (the ‘Company’) Result of Annual General Meeting (‘AGM’) May 8, 2025 The Company announces the voting results of its AGM, held earlier today at the Marlborough Theatre, No. 11 Cavendish Square, London, W1G 0AN. All resolutions were duly passed by shareholders by way of a poll. Details of each resolution are set out in the Notice of Meeting circulated to shareholders on Ma |
|
| May 8, 2025 |
Exhibit 3.1 ARTICLES OF ASSOCIATION of INDIVIOR PLC Public Limited Company (09237894) (Articles adopted by a special resolution on 30 October 2014 and amended by special resolution on 23 December 2014, 30 September 2022, and 4 May 2023 and 8 May 2025) 09237894 TABLE OF CONTENTS 1. EXCLUSION OF MODEL ARTICLES 9 2. DEFINITIONS 9 3. LIMITED LIABILITY 12 4. CHANGE OF NAME 12 5. RIGHTS ATTACHED TO SHAR |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37835 Indivior PLC (Exact name of registrant as specified in |
|
| April 24, 2025 |
Q1 2025 Results April 24, 2025 Exhibit 99.2 Q1 2025 Results | april 24, 2025 Important Cautionary Statement Regarding Forward-looking Statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, express and implied statements regarding: the Company’s financial guidance including revenue, operating, and profit margins for |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 24, 2025 |
Indivior Announces Results for the First Quarter Ended March 31, 2025; FY 2025 Guidance Unchanged Exhibit 99.1 April 24, 2025 Indivior Announces Results for the First Quarter Ended March 31, 2025; FY 2025 Guidance Unchanged • Total Net Revenue (NR) of $266m in Line with Expectations • SUBLOCADE® NR of $176m is Consistent with FY 2025 Guidance of $725m to $765m • On Track to Deliver Gross Annual Operating Expense Savings of Over $100m in FY 2025 Unaudited, $m Q1 2025 Q1 2024 % Change2 Net Reven |
|
| March 27, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 27, 2025 |
Exhibit 99.2 March 27, 2025 Dear Shareholder, I am writing to you today as Chair of Indivior, ahead of our upcoming Annual General Meeting (AGM) on Thursday, May 8th. Indivior was founded to help tackle the global opioid crisis, one of the gravest and most urgent public health emergencies of our time, and it continues to be a global leader in the development of Opioid Use Disorder (OUD) treatments |
|
| March 27, 2025 |
Indivior PLC (the ‘Company’) Publication of Notice of 2025 Annual General Meeting Exhibit 99.1 March 27, 2025 Indivior PLC (the ‘Company’) Publication of Notice of 2025 Annual General Meeting The Company has today published on its website (www.indivior.com/en/investors/shareholder-information) the Notice of 2025 Annual General Meeting (the 'AGM Notice'). In accordance with UK Listing Rule 22.2.6R of the UK Financial Conduct Authority (‘FCA’), copies of the following documents h |
|
| March 27, 2025 |
Exhibit 99.3 March 27, 2025 Dear Shareholder, We are writing to you in our capacity as both outgoing and incoming Chair of the Compensation Committee, to set out planned changes to our Directors’ Remuneration Policy for shareholder approval at our 2025 AGM. As David set out in his letter, it is imperative that Indivior has pay arrangements in place that reward performance and are competitive in co |
|
| March 4, 2025 |
Amended and Restated Relationship Agreement 3 March 2025 INDIVIOR PLC and OAKTREE AMENDED AND RESTATED RELATIONSHIP AGREEMENT THIS AGREEMENT is made on 3 March 2025 BETWEEN: (A)Indivior PLC a company incorporated and registered in the United Kingdom (with company number 09237894) and whose registered office is at 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE (the “Company”); and (B)Oaktree Value Opportunities Fund, L. |
|
| March 4, 2025 |
Execution Copy Without Prejudice & Subject to Contract Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”), dated as of March 3, 2025, is made and entered into by Indivior Inc. (the “Company”) and Joseph Ciaffoni (“Executive”). In consideration of the mutual promises set forth below and other good and valuable consideration, the receipt and sufficiency of which the parti |
|
| March 4, 2025 |
Indivior Announces Further Changes to Board of Directors Exhibit 99.1 Indivior Announces Further Changes to Board of Directors Richmond, VA, March 4, 2025 - Indivior PLC (NASDAQ / LSE: INDV) ("Indivior" or the "Company") today announced that, further to the announcement on December 17, 2024 of certain Director arrangements agreed with Oaktree Capital Management L.P. ("Oaktree"), which advises certain funds that own ordinary shares of Indivior, the annou |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2025 INDIVIOR PLC (Exact name of registrant as specified in its charter) England and Wales 001-37835 98-1204773 (State or other jurisdiction of incorporation) (Commission Fil |
|
| March 3, 2025 |
Exhibit 10.13 PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED. CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE LIKELY TO CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED WITH [***]. 16 December 2024 INDIVIOR PLC and OAKTREE RELATIONSHIP AGREEMENT THIS AGREEMENT is made on 16 December 2024 BETWEEN: (A)Indi |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of March 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| March 3, 2025 |
POL.LEG.10032 Version: 4.0 Status: Effective Effective Date: 12 Jun 2023 Next Review Date: 11 Jun 2025 Last Review Date: Page 1 of 3 Confidential: Downloaded or Printed Copies are uncontrolled and are for reference only on the date of retrieval or printing. Exhibit 19.1 Indivior PLC Group-Wide Dealing Policy Type Policy Number POL.LEG.10032 Level Global Version 4.0 Geographic Impact Global Effecti |
|
| March 3, 2025 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at March 1, 2025 the Company's issued share capital consisted of 124,655,858 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting rig |
|
| March 3, 2025 |
Dated November 19, 2020 Indivior, Inc. - and - Ryan Preblick EMPLOYMENT AGREEMENT Exhibit 10.24.1 INDEX 1. PRELIMINARY............................................................................................................................... 3 2. EMPLOYMENT............................................................................................................................... 3 3. YOUR O |
|
| March 3, 2025 |
Amendment to Employment Agreement =££ INDIVIOR Focus on you. Mark Crossley Via email April 25, 2024 Dear Mark, RE: Amendment to your Confidentiality and Post Termination Restrictions. Following our i ecent discussions, as you are aware, in order to comply with the Securities and Exchange Commission (“SEC”) recent whistleblower enforcements of Rule 2 IF-17 (the “SEC Whistleblower Rules”), certain changes are lequired to your contra |
|
| March 3, 2025 |
The Indivior Inc. Incentive Compensation Policy Incentive Compensation Policy Document Type Policy Document Reference POL.HR.10375 Version Number 6.0 Owning Facility/Site United States Exhibit 10.14 1PURPOSE The Incentive Compensation Policy (“Policy”) describes the governing principles for Incentive Compensation through the Annual Incentive Plan (“AIP”), Commercial Incentive Plan (“CIP”), awards programs, and any individual written employment |
|
| March 3, 2025 |
Master Packaging and Supply Agreement PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED. CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE LIKELY TO CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED WITH [***]. Exhibit 10.10 Execution Version MASTER PACKAGING AND SUPPLY AGREEMENT This Master Packaging and Supply Agreement (the “Agreement”) effecti |
|
| March 3, 2025 |
Rules of the Indivior 2024 Long-Term Incentive Plan Exhibit 10.17 RULES OF THE INDIVIOR 2024 LONG-TERM INCENTIVE PLAN Board Adoption: February 21, 2024 Shareholder Approval: May 9, 2024 Committee Amendment: September 30, 2024 and February 27, 2025 Expiry Date: 2034 AGM The Indivior 2024 Long-term Incentive Plan Introduction An Award under the Plan can take the form of: •A Nil-cost Option - which is a right to buy Shares on Vesting for nothing or a |
|
| March 3, 2025 |
Execution Copy Without Prejudice & Subject to Contract Exhibit 10.23.3 SEPARATION AGREEMENT This Separation Agreement (“Agreement”) is made by and between Indivior, Inc. (the “Company”) and Mark Crossley (“Employee”), dated as of March 2, 2025. WHEREAS, 1.Employee is party to that certain Employment Agreement with the Company, dated June 29, 2020 (the “Employment Agreement”), pursuant to which he |
|
| March 3, 2025 |
Exhibit 10.22 [Date] [Name] [Address] Dear [Name], APPOINTMENT AS NON-EXECUTIVE DIRECTOR I am delighted that you are willing to join us as a Non-Executive Director of Indivior PLC (the “Company”), your appointment to be effective from [date]. I am now writing to formalise and confirm the terms of such appointment. It is agreed that this will be a contract for services and is not a contract of empl |
|
| March 3, 2025 |
The Indivior PLC U.S. Employee Stock Purchase Plan Exhibit 10.20 Indivior PLC U. S. Employee Stock Purchase Plan Approved by shareholders of the Company on May 12, 2016, amended by resolution of the Board of Directors on September 24, 2020, amended by resolution of the Remuneration Committee on February 14, 2023, and amended by resolution of the Remuneration Committee on September 30, 2024 TABLE OF CONTENTS Article I. Purpose and Effective Date 1 |
|
| March 3, 2025 |
Dated June 29, 2020 Indivior, Inc. - and - Mark Crossley EMPLOYMENT AGREEMENT Exhibit 10.23.1 INDEX 1. PRELIMINARY........................................................................................................................ 3 2. EMPLOYMENT........................................................................................................................3 3. YOUR OBLIGATIONS......... |
|
| March 3, 2025 |
Amendment to Employment Agreement ££ INDIVIOR Focus on you. Ryan Preblick Via email April 25, 2024 Dear Ryan, RE: Amendment to your Confidentiality and Post Termination Restrictions. Following our recent discussions, as you are awaie, in older to comply with the Securities and Exchange Commission (“SEC”) recent whistleblower enforcements of Rule 21F-17 (the “SEC Whistleblower Rules”), certam changes are requhed to your contract of |
|
| March 3, 2025 |
Form of Executive Confidentiality, Proprietary Rights and Non-Competition Agreement Exhibit 10.25 CONFIDENTIALITY, PROPRIETARY RIGHTS AND NON-COMPETITION AGREEMENT This Confidentiality, Proprietary Rights and Non-Competition Agreement (the “Agreement”) is entered into as of (Month, Day, Year) (the “Effective Date”), by Indivior, Inc. (“Employer”, collectively with its affiliates, as in existence from time to time, the “Group”) and (Employee Name) (“Employee”). Employer and Employ |
|
| March 3, 2025 |
Execution Version Exhibit 10.12.2 AMENDMENT TO THE LICENSE AGREEMENT This Amendment is entered into as of November 20, 2024 (the “Amendment Effective Date”) by and between Aegis Therapeutics, LLC, having a principal place of business at 3430 Carmel Mount Road, Suite 300, San Diego, CA 92121 (“Aegis”), Indivior Inc., having a principal place of business at 10710 Midlothian Turnpike, Suite 125, Midl |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37835 Indivior PLC (Exact name of registrant as specified in its |
|
| March 3, 2025 |
Subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT The subsidiaries as of December 31, 2024, all of which are included in the consolidated financial statements, are shown below. Name Jurisdiction of Incorporation Indivior Canada Ltd Canada Indivior Deutschland GmbH Germany Indivior España S.L.U. Spain Indivior EU Limited England and Wales Indivior Europe Limited Ireland Indivior Finance LLC Delaware (US) |
|
| March 3, 2025 |
POL.LEG.10031 Version: 5.0 Status: Effective Effective Date: 12 Jun 2023 Next Review Date: 11 Jun 2025 Last Review Date: Page 1 of 11 Confidential: Downloaded or Printed Copies are uncontrolled and are for reference only on the date of retrieval or printing. Exhibit 19.2 Indivior PLC Dealing Code Type Policy Number POL.LEG.10031 Level Global Version 5.0 Geographic Impact Global Effective Date 12 J |
|
| March 3, 2025 |
Indivior PLC Malus & Clawback Policy. EUROPE-LEGAL-282811198/3 168111-0003 Indivior PLC Malus & Clawback Policy Approved by the Remuneration Committee on February 20, 2024 and adopted with effect from May 9, 2024 1. |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 28, 2025 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments; Other Comments Application of Trading Book Exemption (see Section 11 below) 3. Details of person subject to the notification obligation Name Morgan Stanley City of regi |
|
| February 28, 2025 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on February 27, 2025 that Joseph Ciaffoni, a Non-Executive Director of the Company, acquired a total of 56,000 Ordinary Shares of US$0.50 each in the Comp |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 28, 2025 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on February 27, 2025 that Daniel Ninivaggi, a Non-Executive Director of the Company, acquired a total of 15,000 Ordinary Shares of US$0.50 each in the Com |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 27, 2025 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on February 27, 2025 that Robert Schriesheim, a Non-Executive Director of the Company, acquired a total of 58,833 Ordinary Shares of US$0.50 each in the C |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 27, 2025 |
Exhibit 99.1 Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) Indivior PLC has appointed Joe Ciaffoni, currently an Independent Non-Executive Director of the Co |
|
| February 27, 2025 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on February 27, 2025 that Dr. David Wheadon, Chair of the Company, acquired a total of 10,000 Ordinary Shares of US$0.50 each in the Company ('Shares') at |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 25, 2025 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Morgan Stanley City of registered office (if applicable) Country of registered office (if applicable) US Name Ci |
|
| February 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 24, 2025 |
Exhibit 99.1 Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) Richmond, VA, February 24, 2025 - Indivior PLC (Nasdaq/LSE: INDV), a global leader in addictio |
|
| February 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Amendment No. 1 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February, 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) I |
|
| February 20, 2025 |
Announcement sent to London Stock Exchange on February 20, 2025, titled "Final Results." February 20, 2025 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) FY and Q4 2024 Results and FY 2025 Guidance Announced. |
|
| February 20, 2025 |
Announcement furnished to the United States Securities and Exchange Commission on February 20, 2025. February 20, 2025 FY and Q4 2024 Results and FY 2025 Guidance Announced. • FY 2024 net revenue (NR) of $1,188 million, up 9% versus FY 2023 • FY 2024 SUBLOCADE® NR of $756m (+20% versus FY 2023); Q4 2024 NR of $194m • Streamlining actions to save over $100 million annually; reinvesting to support SUBLOCADE long-term growth and Phase II OUD assets as well as delivering over $50m of OPEX savings • F |
|
| February 20, 2025 |
February 20, 2025 FY and Q4 2024 Results and FY 2025 Guidance Announced. • FY 2024 net revenue (NR) of $1,188 million, up 9% versus FY 2023 • FY 2024 SUBLOCADE® NR of $756m (+20% versus FY 2023); Q4 2024 NR of $194m • Streamlining actions to save over $100 million annually; reinvesting to support SUBLOCADE long-term growth and Phase II OUD assets as well as delivering over $50m of OPEX savings • F |
|
| February 20, 2025 |
February 20, 2025 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) FY and Q4 2024 Results and FY 2025 Guidance Announced. |
|
| February 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February, 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| February 13, 2025 |
EX-99.B 3 e664191ex99-b.htm Exhibit B Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934. |
|
| February 13, 2025 |
Exhibit A Joint Filing Agreement The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Ordinary Shares, $0. |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 12, 2025 |
Exhibit 99.1 RNS STATEMENT RE: DELAYED FDA APPROVAL of SUBLOCADE LABEL CHANGES RELEASE DATE: FEBRUARY 12, 2025 RELEASE TIME: 7:00 AM GMT Indivior provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE® (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025: Yesterday, Fe |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 4, 2025 |
INDIVIOR PLC (THE 'COMPANY') Completion of Share Repurchase Program Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') Completion of Share Repurchase Program February 4, 2025 Indivior PLC announces that the share repurchase program announced on July 25, 2024 to repurchase its ordinary shares of $0.50 each (the "Shares") for cancellation has now completed. In aggregate, Morgan Stanley & Co. International Plc, who undertook the program on the Company's behalf, purchased 9,41 |
|
| February 4, 2025 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT February 4, 2025 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 204,247 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from January 27, 2025, up to and including January 31, 2025, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| February 4, 2025 |
Indivior to Announce Q4 / FY 2024 Results and Host Webcast on February 20th Exhibit 99.1 Indivior to Announce Q4 / FY 2024 Results and Host Webcast on February 20th Slough, UK, and Richmond, VA, February 4, 2025 - Indivior PLC (NASDAQ/LSE: INDV) today announced that it will release its Q4 / FY 2024 results on February 20th at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on t |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| February 3, 2025 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at February 1, 2025 the Company's issued share capital consisted of 124,137,286 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting |
|
| February 3, 2025 |
Indivior Appoints Daniel A. Ninivaggi to the Board Exhibit 99.1 Indivior Appoints Daniel A. Ninivaggi to the Board Richmond, VA, February 3, 2025 - Further to the announcement made on Tuesday January 28, the Board of Directors of Indivior PLC is pleased to announce the appointment of Daniel A. Ninivaggi to the Board as an Independent Non-Executive Director with effect from January 31, 2025. Mr. Ninivaggi has significant public company experience a |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of February 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| January 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 28, 2025 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT January 28, 2025 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 171,590 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from January 20, 2025, up to and including January 24, 2025, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| January 28, 2025 |
Exhibit 99.1 Indivior PLC Dr. David Wheadon appointed Chair of the Board Richmond, VA, January 28, 2025 - The Board of Directors of Indivior PLC are pleased to announce the appointment of Dr. David Wheadon as Chair of the Board with immediate effect. Dr. Wheadon joined the Board as a Non-Executive Director in June 2024. His appointment was approved by the Board, following a succession process unde |
|
| January 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 28, 2025 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; Other Comments Application of Trading Book Exemption (see Section 11 below) 3. Details of person subject to the notification obligation Name Morgan Stanley City of registered o |
|
| January 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 27, 2025 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Morgan Stanley City of registered office (if applicable) Country of registered office (if applicable) US Name Ci |
|
| January 21, 2025 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT January 21, 2025 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 222,704 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from January 13, 2025, up to and including January 17, 2025, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| January 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 17, 2025 |
Exhibit 99.1 TRANSACTIONS The following table sets forth all transactions by the Reporting Persons (on behalf of the Funds) with respect to the Ordinary Shares effected in the last 60 days, inclusive of any transactions effected through 4:00 p.m., New York City time, on January 17, 2025. Except as otherwise noted below, all such transactions were purchases or sales of Ordinary Shares effected in t |
|
| January 14, 2025 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT January 14, 2025 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 194,876 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from January 6, 2025, up to and including January 10, 2025, in connection with its $100m Share Repurchase Program. Aggregated info |
|
| January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 10, 2025 |
Indivior Provides Historical Financials in US GAAP Exhibit 99.1 Indivior Provides Historical Financials in US GAAP Slough, UK, and Richmond, VA, January 9, 2025 - Indivior PLC (NASDAQ/LSE: INDV) today has provided historical financial information in US GAAP and certain reconciliations to IFRS as part of its transition to a US primary listing. On May 23, 2024, shareholders overwhelmingly approved moving Indivior's primary listing to the US. Transit |
|
| January 10, 2025 |
6-K 1 a6799s.htm INDIVIOR PROVIDES HISTORICAL FINANCIALS IN US GAAP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia |
|
| January 7, 2025 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT January 7, 2025 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 141,363 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 30, 2024, up to and including January 3, 2025, in connection with its $100m Share Repurchase Program. Aggregated info |
|
| January 7, 2025 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Madison Avenue Partners LP City of registered office (if applicable) New York Country of registered office (if a |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2025 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| January 2, 2025 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at January 1, 2025 the Company's issued share capital consisted of 124,903,607 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting r |
|
| December 31, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT December 31, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 92,950 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 23, 2024, up to and including December 27, 2024, in connection with its $100m Share Repurchase Program. Aggregated i |
|
| December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 31, 2024 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Two Seas Capital LP City of registered office (if applicable) Rye Country of registered office (if applicable) U |
|
| December 26, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT December 24, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 209,246 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 16, 2024, up to and including December 20, 2024, in connection with its $100m Share Repurchase Program. Aggregated |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 23, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on December 20, 2024 that Robert Schriesheim, a Non-Executive Director of the Company, acquired a total of 21,400 Ordinary Shares of US$0.50 each in the C |
|
| December 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 17, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT December 17, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 209,363 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 9, 2024, up to and including December 13, 2024, in connection with its $100m Share Repurchase Program. Aggregated i |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 17, 2024 |
Indivior Announces Changes to Board of Directors Exhibit 99.1 FOR IMMEDIATE RELEASE Indivior Announces Changes to Board of Directors Richmond, VA, December 17, 2024 - Indivior PLC (NASDAQ / LSE: INDV) ("Indivior" or the "Company") today announced that, following recent discussions with Oaktree Capital Management L.P. ("Oaktree"), which advises certain funds that own ordinary shares of Indivior, the Company has agreed to make certain changes to i |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 10, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT December 10, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 250,835 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from December 2, 2024, up to and including December 6, 2024, in connection with its $100m Share Repurchase Program. Aggregated in |
|
| December 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 3, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT December 3, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 420,404 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from November 25, 2024, up to and including November 29, 2024, in connection with its $100m Share Repurchase Program. Aggregated i |
|
| December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| December 2, 2024 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at December 1, 2024 the Company's issued share capital consisted of 125,732,360 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting |
|
| December 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of December 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 26, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT EX-99 2 a5691n.htm EXHIBIT 99.1. Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT November 26, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 374,203 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from November 18, 2024, up to and including November 22, 2024, in connection with its $100m Shar |
|
| November 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 22, 2024 |
Indivior To Participate in Upcoming Investor Event Exhibit 99.1 Indivior To Participate in Upcoming Investor Event Slough, UK, and Richmond, VA, November 22, 2024 – Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor event: ● Piper Sandler 36th Annual Healthcare Conference – New York City, NY Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meet |
|
| November 19, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT November 19, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 316,561 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from November 11, 2024, up to and including November 15, 2024, in connection with its $100m Share Repurchase Program. Aggregated |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 18, 2024 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Madison Avenue Partners LP City of registered office (if ap |
|
| November 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 15, 2024 |
INDIVIOR PLC (the 'Company') DIRECTOR DECLARATION Exhibit 99.1 INDIVIOR PLC (the 'Company') DIRECTOR DECLARATION Richmond, VA, and Slough, UK, November 15, 2024 - The Board of Directors of Indivior PLC (Nasdaq/LSE: INDV) have agreed that Jerome Lande will continue to serve as a Non-Executive Director until December 31, 2024, whereupon he will step down from the Board. The Company's relationship agreement with Scopia Capital Management LP ("Scopia |
|
| November 15, 2024 |
INDV / Indivior PLC / Flynn James E Passive Investment SC 13G 1 e6634034sc13g-ip.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )* Indivior PLC (Name of Issuer) Ordinary Shares, $0.50 nominal value per share (Title of Class of Securities) G4766E116 (CUSIP Nu |
|
| November 14, 2024 |
INDV / Indivior PLC / SCOPIA CAPITAL MANAGEMENT LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 12, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT November 12, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 294,320 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from November 4, 2024, up to and including November 8, 2024, in connection with its $100m Share Repurchase Program. Aggregated in |
|
| November 12, 2024 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Deerfield Management Company, L.P. (Series C) City of registered office (if applicable) Country of registered of |
|
| November 8, 2024 |
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior Exhibit 99.1 Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior Richmond, VA, November 8, 2024 - Indivior PLC (NASDAQ / LSE: INDV) the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ("Oaktree") to the Board of Indivior. The Board has engaged ac |
|
| November 8, 2024 |
Exhibit 10.1 Execution Version PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED. CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE LIKELY TO CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. REDACTED MATERIAL IS MARKED WITH [***]. NOTE PURCHASE AGREEMENT Dated as of November 4, 2024 among RBP GLOBAL HOLDINGS LIMITED, as the Issuer, INDI |
|
| November 8, 2024 |
BLOCK LISTING SIX MONTHLY RETURN Exhibit 99.1 BLOCK LISTING SIX MONTHLY RETURN Date: November 8, 2024 Name of applicant: INDIVIOR PLC Name of scheme: THE INDIVIOR LONG-TERM INCENTIVE PLAN Period of return: From: May 10, 2024 To: November 8, 2024 Balance of unallotted securities under scheme(s) from previous return: 147,096 ORDINARY SHARES OF US$0.50 Plus: The amount by which the block scheme(s) has been increased since the date o |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 For the month of November, 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 8, 2024 |
Exhibit 99.2 Note Purchase Agreement RBP Global Holdings Limited (the “Issuer”), which is an indirect, wholly-owned subsidiary of Indivior PLC, entered into a note purchase agreement dated as of November 4, 2024 with Piper Sandler Finance LLC as Administrative Agent (the “Note Purchase Agreement”) and a group of purchasers (the “Purchasers”). The Note Purchase Agreement provides for the issuance o |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 7, 2024 |
INDV / Indivior PLC / Oaktree Capital Holdings, LLC - SC 13D/A Activist Investment SC 13D/A 1 ef20038241sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* INDIVIOR PLC (Name of Issuer) Ordinary Shares, $0.50 nominal value per share (Title of Class of Securities) G4766E116 (CUSIP Number) Richard Ting General Counsel & Managing Director Oaktree Capital Group Holdings |
|
| November 7, 2024 |
EX-99.1 2 ef20038241ex99-1.htm EXHIBIT 1 EXHIBIT 1 LETTER FROM THE BOARD OF DIRECTORS OF THE ISSUER FROM OAKTREE CAPITAL MAANAGEMENT, L.P. Oaktree Capital Management, L.P. 333 South Grand Avenue, 28th floor Los Angeles, CA 90071 p +1 213 830-6300 oaktreecapital.com November 6, 2024 Board of Directors Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 To the Member |
|
| November 5, 2024 |
6-K 1 indiviorplc-form6k8975k.htm TRANSACTION IN OWN SHARES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| November 5, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT November 5, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 745,703 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from October 28, 2024, up to and including November 1, 2024, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| November 5, 2024 |
Indivior Completes Refinance of Secured Term Loan; Enhances Liquidity and Financial Flexibility Exhibit 99.1 Indivior Completes Refinance of Secured Term Loan; Enhances Liquidity and Financial Flexibility Richmond, VA, November 5, 2024 - Indivior PLC (NASDAQ/LSE: INDV) today announced that its wholly-owned subsidiary, RBP Global Holdings Limited (the "Issuer"), has entered into an agreement with Piper Sandler Finance LLC and certain purchasers for $400 million of senior secured notes, compri |
|
| November 1, 2024 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at November 1, 2024 the Company's issued share capital consisted of 127,219,020 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting |
|
| November 1, 2024 |
6-K 1 a6593k-coversheet.htm TOTAL VOTING RIGHTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of November 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of |
|
| October 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 29, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT October 29, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 324,159 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from October 21, 2024, up to and including October 25, 2024, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| October 24, 2024 |
October 24, 2024 Q3 and YTD 2024 Financial Results • Total Q3 2024 net revenue (NR) of $307m, +13% vs. |
|
| October 24, 2024 |
Rules of the Indivior Group Deferred Bonus Plan EUROPE-LEGAL-292660102/2 168111-0003 INDIVIOR PLC Rules of Indivior Group Deferred Bonus Plan 2018 Approved by a resolution of the Remuneration Committee of the Board on July 19, 20181 Amended by a resolution of the Remuneration Committee of the Board on November 14, 2018 Amended by a resolution of the Remuneration Committee of the Board on February 14, 2023 Amended by a resolution of the Remuneration Committee of the Board on September 30, 2024 1 Note: this Plan has not been approved by shareholders. |
|
| October 24, 2024 |
Rules of the Indivior 2024 Long-Term Incentive Plan. RULES OF THE INDIVIOR 2024 LONG-TERM INCENTIVE PLAN Board Adoption: February 21, 2024 Shareholder Approval: May 9, 2024 Committee Amendment: September 30, 2024 Expiry Date: 2034 AGM Exhibit 99. |
|
| October 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October, 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check ma |
|
| October 24, 2024 |
October 24, 2024 Q3 and YTD 2024 Financial Results • Total Q3 2024 net revenue (NR) of $307m, +13% vs. |
|
| October 24, 2024 |
As filed with the Securities and Exchange Commission on October 24, 2024 As filed with the Securities and Exchange Commission on October 24, 2024 Registration No. |
|
| October 24, 2024 |
Rules of the Indivior 2024 UK Savings Related Share Option Plan. RULES OF THE INDIVIOR 2024 UK SAVINGS RELATED SHARE OPTION PLAN Board Adoption: February 21, 2024 Shareholder Approval: May 9, 2024 Directors’ Approval: September 30, 2024 Expiry Date: 2034 AGM Exhibit 99. |
|
| October 24, 2024 |
As filed with the Securities and Exchange Commission on October 24, 2024 As filed with the Securities and Exchange Commission on October 24, 2024 Registration No. |
|
| October 24, 2024 |
Indivior PLC U.S. Employee Stock Purchase Plan EUROPE-LEGAL-292660356/2 168111-0003 DC: 5974320-4 Indivior PLC U. S. Employee Stock Purchase Plan Approved by shareholders of the Company on May 12, 2016, amended by resolution of the Board of Directors on September 24, 2020, amended by resolution of the Remuneration Committee on February 14, 2023, and amended by resolution of the Remuneration Committee on September 30, 2024 533789038 Exhibit 99. |
|
| October 24, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Indivior PLC (Exact name of Registrant as Specified in its Charter) Type 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Ordinary Shares, $0. |
|
| October 22, 2024 |
6-K 1 a0244j-1.htm TRANSACTION IN OWN SHARES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of prin |
|
| October 22, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT October 22, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 380,788 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from October 14, 2024, up to and including October 18, 2024, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| October 17, 2024 |
INDV / Indivior PLC / Two Seas Capital LP Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* INDIVIOR PLC (Name of Issuer) Ordinary Shares, $0.50 nominal value per share (Title and Class of Securities) G4766E116 (CUSIP Number) Lawrence V. Palermo Two Seas Capital LP 32 Elm Place, 3rd Floor Rye, NY 10580 (646) 420-4504 (Name, Address and Telephon |
|
| October 15, 2024 |
Indivior to Announce Year-to-Date and Q3 2024 Results and Host Webcast on October 24th Exhibit 99.1 Indivior to Announce Year-to-Date and Q3 2024 Results and Host Webcast on October 24th Slough, UK, and Richmond, VA, October 15, 2024 - Indivior PLC (NASDAQ/LSE: INDV) today announced that it will release its year-to-date and Q3 2024 results on October 24th at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News |
|
| October 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 15, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT October 15, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 634,706 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from October 7, 2024, up to and including October 11, 2024, in connection with its $100m Share Repurchase Program. Aggregated info |
|
| October 15, 2024 |
6-K 1 a1359i-1.htm TRANSACTION IN OWN SHARES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of prin |
|
| October 10, 2024 |
Exhibit 99.1 Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion Conference Call Today at 8:00 AM US Eastern THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WI |
|
| October 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 8, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT October 8, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 391,693 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 30, 2024, up to and including October 4, 2024, in connection with its $100m Share Repurchase Program. Aggregated inf |
|
| October 4, 2024 |
INDV / Indivior PLC / Oaktree Capital Holdings, LLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* INDIVIOR PLC (Name of Issuer) Ordinary Shares, $0.50 nominal value per share (Title of Class of Securities) G4766E116 (CUSIP Number) Richard Ting General Counsel & Managing Director Oaktree Capital Group Holdings GP, LLC 333 South Grand Avenue, 28th Floor |
|
| October 4, 2024 |
EX-24.1 2 ef20036708ex24-1.htm EXHIBIT 24.1 EXHIBIT 24.1 JOINT FILING AGREEMENT In accordance with the requirements of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and subject to the limitations set forth therein, the parties set forth below agree to jointly file the Schedule 13D to which this joint filing agreement is attached, and any subsequent amendments thereto, and ha |
|
| October 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 3, 2024 |
INDIVIOR PLC CHAIR SUCCESSION PLAN Exhibit 99.1 INDIVIOR PLC CHAIR SUCCESSION PLAN Richmond, VA, and Slough, UK, October 3, 2024 - Indivior PLC (Nasdaq/LSE: INDV) today announces that Graham Hetherington has informed the Board of his intention to retire as Chair and from the Board at the end of 2024 for personal reasons. Graham has been a member of the Board for five years, including four years as Chair of the Board. The Nomination |
|
| October 1, 2024 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at October 1, 2024 the Company's issued share capital consisted of 129,575,205 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting r |
|
| October 1, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT October 1, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 302,411 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 23, 2024, up to and including September 27, 2024, in connection with its $100m Share Repurchase Program. Aggregated |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of October 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mar |
|
| September 24, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT September 24, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 485,494 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 16, 2024, up to and including September 20, 2024, in connection with its $100m Share Repurchase Program. Aggregat |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 17, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT September 17, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 623,037 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 9, 2024, up to and including September 13, 2024, in connection with its $100m Share Repurchase Program. Aggregate |
|
| September 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 12, 2024 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name BlackRock, Inc City of registered office (if applicable) Wi |
|
| September 10, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT September 10, 2024 INDIVIOR PLC (“Indivior”) announces that it purchased for cancellation a total of 433,485 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from September 2, 2024, up to and including September 6, 2024, in connection with its $100m Share Repurchase Program. Aggregated |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 4, 2024 |
Exhibit 99.1 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder - Primary and Secondary End Points o |
|
| September 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 3, 2024 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at September 1, 2024 the Company's issued share capital consisted of 131,459,324 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting |
|
| September 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of September 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check m |
|
| September 3, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT September 3, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 296,096 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from August 27, 2024, up to and including August 30, 2024, in connection with its $100m Share Repurchase Program. Aggregated info |
|
| August 27, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT August 27, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 518,936 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from August 19, 2024, up to and including August 23, 2024, in connection with its $100m Share Repurchase Program. Aggregated inform |
|
| August 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 20, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT August 20, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 574,816 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from August 12, 2024, up to and including August 16, 2024, in connection with its $100m Share Repurchase Program. Aggregated inform |
|
| August 20, 2024 |
Indivior To Participate in Upcoming Investor Events Exhibit 99.1 Indivior To Participate in Upcoming Investor Events Slough, UK, and Richmond, VA, August 20, 2024 - Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events: ● Morgan Stanley 22nd Annual Global Healthcare Conference - New York City Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group |
|
| August 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 14, 2024 |
TR-1: Standard form for notification of major holdings Exhibit 99.1 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BN4HT335 Issuer Name INDIVIOR PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of financial instruments 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if a |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 13, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT August 13, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 601,740 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from August 5, 2024, up to and including August 9, 2024, in connection with its $100m Share Repurchase Program. Aggregated informat |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| August 6, 2024 |
INDIVIOR PLC (THE 'COMPANY') Completion of Share Repurchase Program Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') Completion of Share Repurchase Program August 6, 2024 Indivior PLC announces that the share repurchase program announced on November 17, 2023 to repurchase its ordinary shares of $0.50 each (the "Shares") for cancellation has now completed. In aggregate, Morgan Stanley & Co. International Plc, who undertook the program on the Company's behalf, purchased 5, |
|
| August 6, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT August 6, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 285,437 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from July 29, 2024, up to and including August 2, 2024, in connection with its $100m Share Repurchase Program. Aggregated informatio |
|
| August 1, 2024 |
INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') TOTAL VOTING RIGHTS AND CAPITAL In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company hereby notifies the market that as at August 1, 2024 the Company's issued share capital consisted of 133,736,349 Ordinary Shares of US$0.50 each. The Company does not hold any shares in Treasury. Therefore, the total number of voting ri |
|
| August 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 30, 2024 |
INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT EX-99 2 indiviorplc.htm EXHIBIT 99.1 Exhibit 99.1 INDIVIOR PLC SHARE REPURCHASE PROGRAM WEEKLY REPORT July 30, 2024 INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 52,171 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from July 22, 2024, up to and including July 26, 2024, in connection with its $100m Share Repurch |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 30, 2024 |
EX-99 2 a4404y-announcement.htm EXHIBIT 99.1 Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 29, 2024 that Juliet Thompson, a Non-Executive Director of the Company, and Timothy Thompson, a perso |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 30, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 29, 2024 that Dr. Keith Humphreys, a Non-Executive Director of the Company, acquired 775 Ordinary Shares of US$0.50 each in the Company ('Shares') |
|
| July 30, 2024 |
Indivior PLC (the "Company") - Block listings of shares Exhibit 99.1 Indivior PLC (the "Company") - Block listings of shares Application has been made to the UK Listing Authority and the London Stock Exchange for the block listings of a total of 4,600,000 Ordinary Shares of US$0.50 each ("Shares") to trade on the London Stock Exchange and to be admitted to the Official List. The Shares will be issued to satisfy the vesting of share awards under the fol |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 29, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 26, 2024 that Mark Crossley, a PDMR and the Chief Executive of the Company, purchased 7,639 Ordinary Shares of US$0.50 each in the Company ('Share |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 29, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 28, 2024 that Jeff Burris, a PDMR and the Company's Chief Legal Officer, acquired 760 Ordinary Shares of US$0.50 each in the Company ('Shares') at |
|
| July 29, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 26, 2024 that Mark Stejbach, a Non-Executive Director of the Company, purchased 790 Ordinary Shares of US$0.50 each in the Company ('Shares') at a |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 29, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 26, 2024 that Vishal Kalia, a PDMR and Company's Chief Strategy and Global Impact Officer, purchased 4,664 Ordinary Shares of US$0.50 each in the |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
|
| July 26, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 26, 2024 that Joanna Le Couilliard, a Non-Executive Director of the Company, acquired 1,490 Ordinary Shares of US$0.50 each in the Company ('Share |
|
| July 26, 2024 |
Exhibit 99.1 INDIVIOR PLC (THE 'COMPANY') NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM The Company announces that it received notification on July 26, 2024 that Graham Hetherington, a Non-Executive Director of the Company, acquired 850 Ordinary Shares of US$0.50 each in the Company ('Shares') |
|
| July 25, 2024 |
July 25, 2024 Q2 2024 Results In Line with Updated Guidance; $100m Share Buyback Announced • Reports Q2 2024 SUBLOCADE® Net Revenue (NR) of $192m (+24% versus Q2 2023) • Announces new $100m share repurchase program • Announces expected settlement of certain opioid litigation (See Notes 11 and 13). |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July, 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of July 2024 Commission File Number: 001-37835 Indivior PLC 10710 Midlothian Turnpike, Suite 125 North Chesterfield, Virginia 23235 (Address of principal executive office) Indicate by check mark w |
